Search Results - "FORNIER, Monica N"

Microtubule Active Agents: Beyond the Taxane Frontier by MORRIS, Patrick G, FORNIER, Monica N

“…Microtubules are essential to cell transport, signaling, and mitosis. An increasing range of anticancer drugs interferes with the normal formation and function…”
Get full text

NCCN Task Force Report: Bone Health In Cancer Care by Gralow, Julie R, Biermann, J Sybil, Farooki, Azeez, Fornier, Monica N, Gagel, Robert F, Kumar, Rashmi, Litsas, Georgia, McKay, Rana, Podoloff, Donald A, Srinivas, Sandy, Van Poznak, Catherine H

“…Bone health and maintenance of bone integrity are important components of comprehensive cancer care. Many patients with cancer are at risk for therapy-induced…”
Get more information

Denosumab: second chapter in controlling bone metastases or a new book? by Fornier, Monica N

Get full text

Long-term Clinical Outcomes of Whole-Breast Irradiation Delivered in the Prone Position by Stegman, Lauren D., M.D., Ph.D, Beal, Katherine P., M.D, Hunt, Margie A., M.S, Fornier, Monica N., M.D, McCormick, Beryl, M.D

“…Purpose The aim of this study was to evaluate retrospectively the effectiveness and toxicity of post-lumpectomy whole-breast radiation therapy delivered with…”
Get full text

Locoregional Outcomes of Inflammatory Breast Cancer Patients Treated With Standard Fractionation Radiation and Daily Skin Bolus in the Taxane Era by Damast, Shari, M.D, Ho, Alice Y., M.D, Montgomery, Leslie, M.D, Fornier, Monica N., M.D, Ishill, Nicole, M.S, Elkin, Elena, Ph.D, Beal, Kathryn, M.D, McCormick, Beryl, M.D

“…Purpose To assess locoregional outcomes of inflammatory breast cancer (IBC) patients who received standard fractionation radiation with daily skin bolus and…”
Get full text

Weekly Trastuzumab and Paclitaxel Therapy for Metastatic Breast Cancer With Analysis of Efficacy by HER2 Immunophenotype and Gene Amplification by SEIDMAN, Andrew D, FORNIER, Monica N, GILEWSKI, Teresa, THEODOULOU, Maria, MOYNAHAN, Mary Ellen, MOASSER, Mark, SKLARIN, Nancy, DICKLER, Maura, D'ANDREA, Gabriella, CRISTOFANILLI, Massimo, RIVERA, Edgardo, HORTOBAGYI, Gabriel N, ESTEVA, Francisco J, NORTON, Larry, HUDIS, Clifford A, LEE TAN, KAPTAIN, Stamatina, BACH, Ariadne, PANAGEAS, Katherine S, ARROYO, Crispinita, VALERO, Vicente, CURRIE, Violante

“…This phase II study evaluated weekly trastuzumab and paclitaxel therapy in women with HER2-normal and HER2-overexpressing metastatic breast cancer. Efficacy…”
Get full text

Assessing fracture risk in early stage breast cancer patients treated with aromatase-inhibitors: An enhanced screening approach incorporating trabecular bone score by Mariotti, Veronica, Page, David B, Davydov, Oksana, Hans, Didier, Hudis, Clifford A, Patil, Sujata, Kunte, Siddharth, Girotra, Monica, Farooki, Azeez, Fornier, Monica N

“…Abstract Introduction Aromatase-inhibitors (AIs) are commonly used for treatment of patients with hormone-receptor positive breast carcinoma, and are known to…”
Get full text

Serum N-Telopeptide and Bone-Specific Alkaline Phosphatase Levels in Patients With Osteonecrosis of the Jaw Receiving Bisphosphonates for Bone Metastases by Morris, Patrick G., MD, Fazio, Maurizio, Farooki, Azeez, MD, Estilo, Cherry, DMD, Mallam, Divya, Conlin, Alison, MD, Patil, Sujata, PhD, Fleisher, Martin, PhD, Cremers, Serge, PhD, Huryn, Joseph, DDS, Hudis, Clifford A., MD, Fornier, Monica N., MD

“…Purpose Oversuppression of bone turnover can be a critical factor in the pathogenesis of osteonecrosis of the jaw (ONJ). We investigated N-telopeptide of type…”
Get full text

A Phase I Study of Alpelisib in Combination with Trastuzumab and LJM716 in Patients with PIK3CA -Mutated HER2-Positive Metastatic Breast Cancer by Jhaveri, Komal, Drago, Joshua Z, Shah, Payal Deepak, Wang, Rui, Pareja, Fresia, Ratzon, Fanni, Iasonos, Alexia, Patil, Sujata, Rosen, Neal, Fornier, Monica N, Sklarin, Nancy T, Chandarlapaty, Sarat, Modi, Shanu

“…Activating mutations in promote resistance to HER2-targeted therapy in breast cancer; however, inhibition of PI3K alone leads to escape via feedback…”
Get full text

Oral minoxidil for late alopecia in cancer survivors by Kuo, Alyce Mei-Shiuan, Reingold, Rachel E., Ketosugbo, Kwami F., Pan, Alexander, Kraehenbuehl, Lukas, Dusza, Stephen, Gajria, Devika, Lake, Diana E., Bromberg, Jacqueline F., Traina, Tiffany A., Fornier, Monica N., Gucalp, Ayca, D’Alessandro, Brian M., Rotemberg, Veronica, Dauscher, Megan, Shapiro, Jerry, Goldfarb, Shari B., Markova, Alina, Lacouture, Mario E.

“…Purpose Late alopecia, defined as incomplete hair regrowth > 6 months following cytotoxic chemotherapy or > 6 months from initiation of endocrine therapy,…”
Get full text

Approved Agents for Metastatic Breast Cancer by Fornier, Monica N

“…The US Food and Drug Administration has approved three agents for treatment of patients with metastatic breast cancer refractory to anthracyclines and taxanes:…”
Get full text

Does preoperative MRI accurately stratify early-stage HER2 + breast cancer patients to upfront surgery vs neoadjuvant chemotherapy? by Botty van den Bruele, Astrid, Ferraro, Emanuela, Sevilimedu, Varadan, Hogan, Molly P., Javed-Tayyab, Sidra, Le, Tiana, Fornier, Monica N., Morrow, Monica, Sacchini, Virgilio

“…Purpose HER2 +- amplified breast cancer patients derive benefit from treatment with anti-HER2-targeted therapy. Though adjuvant treatment is based on final…”
Get full text

Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer by Morris, Patrick G., Rota, Selene, Cadoo, Karen, Zamora, Stephen, Patil, Sujata, D'Andrea, Gabriella, Gilewski, Theresa, Bromberg, Jacqueline, Dang, Chau, Dickler, Maura, Modi, Shanu, Seidman, Andrew D., Sklarin, Nancy, Norton, Larry, Hudis, Clifford A., Fornier, Monica N.

“…Overexpression and activation of tyrosine kinase Src has been linked to breast carcinogenesis and bone metastases. We conducted a phase II trial in patients…”
Get full text

Increased Dose Density Is Feasible: A Pilot Study of Adjuvant Epirubicin and Cyclophosphamide followed by Paclitaxel, at 10- or 11-Day Intervals with Filgrastim Support in Women with Breast Cancer by FORNIER, Monica N, SEIDMAN, Andrew D, HUDIS, Clifford, LAKE, Diana, D'ANDREA, Gabriella, BROMBERG, Jacqueline, ROBSON, Mark, VAN POZNAK, Catherine, PANAGEAS, Katherine S, ATIENZA, Marietta, NORTON, Larry

“…Purpose: Because Cancer and Leukemia Group B 9741 trial showed a benefit for every 14-day administration of chemotherapy compared with every 21-day treatment,…”
Get full text

Molecular downstaging: a new paradigm for neoadjuvant endocrine therapy by Ferraro, Emanuela, Fornier, Monica N

Get full text

NCCN Task Force Report: Bone Health in Cancer Care by Gralow, Julie R, Biermann, J Sybil, Farooki, Azeez, Fornier, Monica N, Gagel, Robert F, Kumar, Rashmi N, Shapiro, Charles L, Shields, Andrew, Smith, Matthew R, Srinivas, Sandy, Van Poznak, Catherine H

“…Bone health and maintenance of bone integrity are important components of comprehensive cancer care in both early and late stages of disease. Risk factors for…”
Get more information

Less Intense Dosing Schedule for a Bone-Modifying Agent by Fornier, Monica N

Get more information

Incidence of chemotherapy‐induced, long‐term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane by Fornier, Monica N., Modi, Shanu, Panageas, Katherine S., Norton, Larry, Hudis, Clifford

“…BACKGROUND Twenty‐five percent of all women with breast carcinoma are premenopausal and are at risk for chemotherapy‐induced menopause with long‐term side…”
Get full text

Increased Levels of Urinary PGE-M, a Biomarker of Inflammation, Occur in Association with Obesity, Aging, and Lung Metastases in Patients with Breast Cancer by MORRIS, Patrick G, ZHOU, Xi Kathy, MILNE, Ginger L, GOLDSTEIN, Daniel, HAWKS, Laura C, DANG, Chau T, MODI, Shanu, FORNIER, Monica N, HUDIS, Clifford A, DANNENBERG, Andrew J

“…Elevated levels of COX-derived prostaglandin E2 (PGE2) occur in inflamed tissues. To evaluate the potential links between inflammation and breast cancer,…”
Get full text

Utilizing Microtubule Dynamics Inhibitor Therapeutics in the Management of Patients With Metastatic Breast Cancer by Seidman, Andrew D, Brufsky, Adam, Fornier, Monica N

Get full text